About Our Approach to Cutaneous T-Cell Lymphoma:
A patch that has been called eczema, then psoriasis, then eczema again —
and never fully cleared — has earned a biopsy.
At Charleston Dermatology, our team evaluates treatment-resistant patches and
plaques with skin biopsies and specialized pathology. Early CTCL is
notoriously subtle under the microscope, so more than one biopsy over time is
sometimes needed to confirm the diagnosis and stage it accurately.
Treatment is built around your stage. CTCL is not treated with Mohs surgery —
early disease responds to skin-directed therapies like prescription topicals,
phototherapy, and radiation, while advanced disease is managed with oncology.
Diagnosed early, most patients live normal lifespans with well-controlled
disease. Schedule a visit for any rash that refuses to behave.
Frequently Asked Questions
What does cutaneous T-cell lymphoma look like?
The most common form, mycosis fungoides, starts as flat, scaly, discolored patches — often on the buttocks, trunk, and thighs, areas the sun rarely reaches. Over years, patches can thicken into raised plaques. Persistent itch is common. Because it mimics everyday rashes, the average patient waits years for a correct diagnosis.
Why isn't CTCL treated with surgery?
CTCL involves immune cells that circulate through the skin, so cutting out one patch doesn’t address the disease — treatment needs to cover the affected skin as a whole. That’s why skin-directed therapies like phototherapy and topical prescriptions, or radiation for thicker lesions, are the mainstays instead of excision.
What is the outlook for CTCL?
For early-stage disease — the majority of diagnoses — the outlook is very good, and many patients keep the disease quiet for decades with maintenance treatment. The goal is control rather than cure, similar to managing other chronic conditions. Regular follow-up lets us adjust treatment as needed and catch any progression early.